小容量局部麻醉药髋关节囊周围神经阻滞用于髋关节镜术的围手术期管理:单中心双盲随机对照试验
该单中心双盲随机对照试验纳入90例髋关节镜手术患者,随机分为髂筋膜间隙阻滞组、20 ml局部麻醉药髋关节囊周围神经阻滞(PENG)组和10 ml局部麻醉药PENG组。三组术后2小时及1天NRS评分无显著差异,但10 ml PENG组术后2小时股四头肌肌力优于20 ml PENG组和髂筋膜间隙阻滞组,恢复质量评分也更高,但恢复质量改善幅度未超过最小临床重要差异。
要点
- 三组术后2小时和1天NRS评分无显著差异。
- 术后2小时股四头肌肌力:PENG 10 ml组3.43±0.45优于PENG 20 ml组2.43±1.81和FICB组0.57±0.82(p<0.001)。
- 恢复质量评分:PENG 10 ml组125.57±4.70高于PENG 20 ml组123.53±5.45和FICB组120.80±3.34(p<0.01),但改善幅度未超过最小临床重要差异。
核心结论
- 髋关节镜手术患者术前接受FICB、PENG(10 mL)或PENG(20 mL)阻滞,术中应激反应和术后镇痛效果相当。
- 接受小容量PENG阻滞的患者术后股四头肌肌力保留更优,恢复质量有统计学显著改善,但改善幅度未超过最小临床重要差异。
研究设计与样本
- 单中心、双盲、随机对照试验,共纳入90例接受髋关节镜手术的患者,随机分为三组。
- 第一组接受髂筋膜间隙阻滞(FICB),第二组接受20 ml局部麻醉药的髋关节囊周围神经阻滞(PENG),第三组接受10 ml局部麻醉药的PENG阻滞。
- 主要结局指标为术后股四头肌肌力;次要结局包括术后2小时数字评定量表(NRS)评分、术中血压和心率变化、术后1天NRS评分、术中及术后阿片类药物消耗量、术后并发症、住院时长、患者满意度、疼痛体验和恢复质量。
- 试验注册号:ChiCTR2400091099,注册日期2024年10月21日,回顾性注册。
主要发现
- 三组基本统计参数无差异证据,术后2小时和1天NRS评分无显著差异。
- 术后2小时股四头肌肌力三组间差异显著:PENG 10 ml组3.43±0.45,PENG 20 ml组2.43±1.81,FICB组0.57±0.82(p<0.001)。
- 术后恢复质量评分三组间有差异:PENG 10 ml组125.57±4.70,PENG 20 ml组123.53±5.45,FICB组120.80±3.34(p<0.01)。
- 其他结局指标均无显著差异。
局限性
- 试验为回顾性注册(注册日期2024年10月21日)。
- 恢复质量改善幅度未超过最小临床重要差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Current analgesic options for hip arthroscopy include fascia iliaca block and peripheral nerve block of the hip. Although the latter provides effective analgesia with reduced motor impairment compared with the fascia iliaca approach, motor blockade still occurs in ≥ 25% of patients. This study aimed to investigate whether administering low-volume local anesthetic for peripheral nerve blockade in the hip reduces the incidence of postoperative quadriceps weakness while maintaining adequate pain control. METHODS: A total of 90 patients who underwent hip arthroscopy were randomly assigned to one of three groups. The first group was administered a fascia iliaca compartment block (FICB), the second group was administered a pericapsular nerve group (PENG) block with 20 ml of local anesthetic, and the third group was administered a PENG block with 10 ml of local anesthetic. The primary outcome measure was postoperative quadriceps muscle strength, whereas the secondary outcome measures were the postoperative 2-h Numeric Rating Scale (NRS) score, intraoperative changes in blood pressure and heart rate, NRS score at one day after surgery, intraoperative and postoperative opioid consumption, postoperative complications, length of hospital stay, patient satisfaction, pain experience, and quality of recovery. RESULTS: No evidence of a difference were observed in the basic statistical parameters among the three patient groups. Moreover, no significant discrepancies were identified in the NRS scores at the 2-h or 1-day post-operative intervals. However, a marked difference in quadriceps muscle strength was evident among the three groups at the 2-h post-operative mark (PENG 10 ml = 3.43 ± 0.45, PENG 20 ml = 2.43 ± 1.81, FICB = 0.57 ± 0.82; p < 0.001). There was a difference in the quality of postoperative recovery (PENG 10 ml = 125.57 ± 4.70, PENG 20 ml = 123.53 ± 5.45, FICB = 120.80 ± 3.34; p < 0.01), with no significant difference in any other outcome. CONCLUSIONS: In patients undergoing hip arthroscopy, preoperative FICB, PENG (10 mL), and PENG (20 mL) blocks resulted in comparable intraoperative stress responses and provided comparable, satisfactory postoperative analgesia.However, patients who received low-volume PENG blocks demonstrated superior postoperative preservation of quadriceps muscle strength and a statistically significant improvement in the quality of recovery. Notably, the magnitude of this improvement in recovery quality did not exceed the minimal clinically important difference. TRIAL REGISTRATION NUMBER: ChiCTR2400091099. Date: October 21, 2024; retrospectively registered. URL: https://www.chictr.org.cn/ .
引用
- Zhang C, Fan Y, Li P, et al. Satisfactory perioperative management for hip arthroscopy with small local pericapsular nerve group block: a single-center, double-blind, randomized controlled trial. Trials. 2025. PMID: 41454400. doi:10.1186/s13063-025-09407-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。